A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia
Clinical trial NCT02011945 · COMPLETED
Trial details
- NCT number
- NCT02011945
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-07
- Primary completion
- 2018-12-26
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.